drugset / Trial / NCT06467084
Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II
Non-randomizedParallel-groupOpen-labelTreatment
Summary
KVD900-303 is an open-label, multicenter clinical trial in patients aged 2 to 11 years old with HAE Type I or II.
Timeline
- Start
- 2024-06-24
- Primary completion
- 2026-01-15
- Completion
- 2026-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sebetralstat | Small molecule | 150 mg | — |
| Subject | Sebetralstat | Small molecule | 300 mg | — |
| Subject | Sebetralstat | Small molecule | 600 mg | — |